Happy new year!

Everyone at the Swiss NASH Foundation wishes you a happy and healthy new year 2024!

Swiss NASH Foundation Follow

Fostering NASH research and sharing knowledge about living with NASH

Retweet on Twitter Swiss NASH Foundation Retweeted

Lorenza Rimassa @lorenzarimassa ·

20 Oct

Peter Galle presents ABC-HCC, academic study of atezolizumab-bevacizumab vs TACE for intermediate stage #HCC.
Improved time to failure of treatment strategy with #systemic therapy.
Positive study, potential novel approach for #intermediate HCC
#ESMO25 #ESMOAmbassadors @myESMO

Retweet on Twitter Swiss NASH Foundation Retweeted

Scott Isaacs @scottisaacsmd ·

18 Nov

One of the reasons why it is so difficult to maintain weight loss is because adipose issue retains an epigenetic memory of obesity after weight loss.
https://www.nature.com/articles/s41586-024-08165-7

Retweet on Twitter Swiss NASH Foundation Retweeted

Jean-Charles Nault @naultjc ·

26 Jul 2024

1) Our manuscript entitled « Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments” was recently released in Gut
https://gut.bmj.com/content/early/2024/07/25/gutjnl-2024-331956?rss=1
@campani_claudia @CRCordeliers @SRebouissou @GUTJournal_BMJ @TZ_Hirsch @SImbeaud

Retweet on Twitter Swiss NASH Foundation Retweeted

Gut Journal @gut_bmj ·

11 May 2024

Read the new @BritSocGastro #GUTGuideline by Suddle et al entitled

"British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults" via https://bit.ly/3UudyX8

@DinaTiniakos #HCC

< Back to all news

2 January 2024